A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial
In: British journal of haematology, Jg. 185 (2019), Heft 4, S. 691-700
serialPeriodical
Zugriff:
Titel: |
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial
|
---|---|
Autor/in / Beteiligte Person: | Gisslinger, Heinz ; Buxhofer‐Ausch, Veronika ; Hodisch, Juri ; Radinoff, Atanas ; Karyagina, Elena ; Kyrcz‐Krzemień, Slawomira ; Abdulkadyrov, Kudrat ; Gerbutavicius, Rolandas ; Melikyan, Anait ; Burgstaller, Sonja ; Hus, Marek ; Kłoczko, Janusz ; Yablokova, Vera ; Tzvetkov, Nikolay ; Całbecka, Malgorzata ; Shneyder, Tatyana ; Warzocha, Krzysztof ; Jurgutis, Mindaugas ; Kaplanov, Kamil ; Jilma, Bernd ; Schoergenhofer, Christian ; Klade, Christoph |
Link: | |
Zeitschrift: | British journal of haematology, Jg. 185 (2019), Heft 4, S. 691-700 |
Veröffentlichung: | 2019 |
Medientyp: | serialPeriodical |
ISSN: | 0007-1048 (print) |
Sonstiges: |
|